The Drug Regulatory Authority hereby notifies the general public to be cautious of self medicating with fixed dose combination products (medicines containing more than one active ingredients) containing steroids for the treatment of skin infections.
Irrational use of such combination products for a longer period of time may develop resistance in the patient and he/she will fail to respond to the same medicine next time.
Therefore, we urge the public to refrain from using any combination products if it is not prescribed by the medical doctors.
For further information and clarification, please contact office of the Drug Controller, DRA at 337074 or 337075
February 27th, 2024
February 7th, 2024
February 5th, 2024
January 25th, 2024
December 27th, 2023
November 3rd, 2023